These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3446165)

  • 41. Use of aminoglycosides in critically ill patients: individualization of dosage using Bayesian statistics and pharmacokinetic principles.
    Böttger HC; Oellerich M; Sybrecht GW
    Ther Drug Monit; 1988; 10(3):280-6. PubMed ID: 3176103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased aminoglycoside dosage requirements in hematologic malignancy.
    Zeitany RG; El Saghir NS; Santhosh-Kumar CR; Sigmon MA
    Antimicrob Agents Chemother; 1990 May; 34(5):702-8. PubMed ID: 2360811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of once-daily gentamicin dosing in pediatric patients.
    Bass KD; Larkin SE; Paap C; Haase GM
    J Pediatr Surg; 1998 Jul; 33(7):1104-7. PubMed ID: 9694103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
    McDade EJ; Wagner JL; Moffett BS; Palazzi DL
    Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Appropriateness of a 4 mg/kg gentamicin or tobramycin loading dose in post-operative septic shock patients.
    Oparaoji EC; Siram S; Shoheiber O; Cornwell EE; Mezghebe HM
    J Clin Pharm Ther; 1998 Jun; 23(3):185-90. PubMed ID: 9831969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
    Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
    J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring.
    Nicolau DP; Wu AH; Finocchiaro S; Udeh E; Chow MS; Quintiliani R; Nightingale CH
    Ther Drug Monit; 1996 Jun; 18(3):263-6. PubMed ID: 8738765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates.
    Valitalo PA; van den Anker JN; Allegaert K; de Cock RF; de Hoog M; Simons SH; Mouton JW; Knibbe CA
    J Antimicrob Chemother; 2015 Jul; 70(7):2074-7. PubMed ID: 25766737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective.
    Massey KL; Hendeles L; Neims A
    J Pediatr; 1986 Nov; 109(5):897-901. PubMed ID: 3095524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variability in aminoglycoside pharmacokinetics in critically ill surgical patients.
    Dasta JF; Armstrong DK
    Crit Care Med; 1988 Apr; 16(4):327-30. PubMed ID: 3349791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
    Chuk AC; Saeed F; Kousar N; Burrill S; Barns B; Rickrode G; Fu J; Katrych O; Saunders-Hao P; Block C; Lahey T
    Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections.
    Carapetis JR; Jaquiery AL; Buttery JP; Starr M; Cranswick NE; Kohn S; Hogg GG; Woods S; Grimwood K
    Pediatr Infect Dis J; 2001 Mar; 20(3):240-6. PubMed ID: 11303823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic variability of extended interval tobramycin in burn patients.
    Bracco D; Landry C; Dubois MJ; Eggimann P
    Burns; 2008 Sep; 34(6):791-6. PubMed ID: 18395988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis.
    Bates RD; Nahata MC; Jones JW; McCoy K; Young G; Cox S; Barson WJ
    Chest; 1997 Nov; 112(5):1208-13. PubMed ID: 9367459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.
    Grucz TM; Kruer RM; Bernice F; Lipsett PA; Dorman T; Sugrue D; Jarrell AS
    Surg Infect (Larchmt); 2020 Dec; 21(10):859-864. PubMed ID: 32302517
    [No Abstract]   [Full Text] [Related]  

  • 57. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
    Rao SC; Ahmed M; Hagan R
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A dose-ranging study of gentamicin pharmacokinetics: implications for extended interval aminoglycoside therapy.
    McNamara DR; Nafziger AN; Menhinick AM; Bertino JS
    J Clin Pharmacol; 2001 Apr; 41(4):374-7. PubMed ID: 11304893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.